Early on during the onset of the virus, Peter Diamandis which we wrote about here, and here, confidently said not only would there be a vaccine but there would be multiple vaccines.
One thing Diamandis missed on his estimate would be a 50% to 75% cure rate but a cocktail of vaccines combination in order to get the cure rate much higher.
Early last week Pfizer‘s announcement of an approximate 90% cure rate was one upped early this week by Moderna.
Moderna claims almost 94% cure rate
In this press release by fellow drug research and manufacturing firm Moderna their initial trials claim a possible near 94% cure rate.
Of course these are early Stage III trials but on top of the earlier Pfizer news from last week this is very exciting.
One additional positive on the Moderna over the Pfizer is their initial thoughts are the vaccine does not have to be kept at the extreme low temperature as the Pfizer trials.
In a glass is half full fashion if Diamandis correct we should expect even more vaccines to have positive curate and to be available in the market sooner rather than later.
The Future Is Really Brighter than We Think!
Have a “Vaccine is On the Way’ Day!
John A. Kvale CFA, CFP
Founder of J.K. Financial, Inc.
A Dallas Texas based fee only
Financial Planning Total Wealth
Management firm.
November 2020 Podcast Video, Financial Planning and Capital Market Update – By John Kvale …
Hello and Welcome to our November 2020 Financial Planning and Capital Market Update!
If you are too busy to read, feel free to listen as we describe our post and thoughts in friendly podcast audio format as well as Video!
Newbies –
We like to articulate our thoughts and review on a Monthly basis our Financial Planning Tips, Capital Markets and current events!
Hope you enjoy!
November Video
(YouTube)
Financial Planning Tip (s) –
Vaccines (Times 3 and Counting) are Coming
In a great way to start the week for the past three weeks, each Monday has sported a breakthrough Vaccine announcement, first it was Pfizer, then Moderna and most recently Astrazeneca … WOW what a great way to start the week(s).
Capital Market Comments
Muted Reaction to Vaccine
Many thought the markets would have roared more post trifecta Vaccine announcements above … under the surface many companies left for dead HAVE roared, and markets have edged higher, but as mentioned most recently earlier here at current levels markets are pricing in a lot of good news already and likely are well ahead of themselves.
Have a Great November Update!
Talk to you at the end of December!
John A. Kvale CFA, CFP
Founder of J.K. Financial, Inc.
A Dallas Texas based fee only
Financial Planning Total Wealth
Management firm.
jkfinancialinc
street-cents
Share this:
Like this:
Leave a comment
Posted in General Financial Planning, Investing/Financial Planning, Market Comments, Monthly Review
Tagged Astrazeneca, Moderna, Pfizer, Vaccine